MedTrace Logo

IPF Italian Observational Study (FIBRONET) in Idiopathic Pulmonary Fibrosis

NCT02803580 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 209

Last updated 2019-09-13

Study results available
· View outcomes & findings →

Summary

The purpose of the present study is to evaluate the characteristics, management and clinical course of patients with IPF as treated under real-world in Italian Pulmonary Centres, in terms of symptoms, lung function and exercise tolerance during 12 months of observation.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Boehringer Ingelheim · Boehringer Ingelheim

Eligibility

Min Age
40 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-17
Primary Completion
2018-05-15
Completion
2018-05-15

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02803580 on ClinicalTrials.gov